Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by tradingsteveon Aug 31, 2010 1:46am
563 Views
Post# 17398287

RE: RE: SSS News Release....(since others are too

RE: RE: SSS News Release....(since others are tooactually sucker (nice name).....as i previously disclosed my position is at
.057, which makes the "swampland" your referring to quite cheap and appealling.....longs are in deep on this one, no doubt....but some of us got out and then back in at a much better position and are comfortable with the price paid for the risk/reward......

anyone trading this one would have made a killing a few times over in the last 2 months........maybe you're just bitter you bought someone else's swampland?????
Bullboard Posts